It is a pharma private limited company based in Thane, Maharashtra, India, established in 2013.
2013 | Thane, Maharashtra, India | ActiveSprash Pharmaceutical Private Limited, a active private limited company, was established on 07 November 2013 in Thane, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24233MH2013PTC249883. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Manisha Parmeshwar Lambud (Director), Radha Dattatray Walaskar (Director), Parmeshwar Annasaheb Lambud (Managing Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat No. 302, 3Rd Floor, Tirupati Gaurav Society Survey No. 416/2, Belapur, Thane, Maharashtra, 400614.
U24233MH2013PTC249883
249883
07 November 2013
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Sprash Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manisha Parmeshwar Lambud | Director | 07 Nov 2013 | Current |
| Radha Dattatray Walaskar | Director | 07 Nov 2013 | Current |
| Parmeshwar Annasaheb Lambud | Managing Director | 07 Nov 2013 | Current |
| Vijaya Vinod Lambud | Director | 07 Nov 2013 | Current |
| Dattatraya Dnyanoba Walaskar | Director | 07 Nov 2013 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sprash Pharmaceutical Private Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 32.76% increase in profit. The company's net worth dipped by a decrease of 7.49%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Sprash Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Sprash Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sprash Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sprash Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Sprash Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Sprash Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Manisha Parmeshwar Lambud was appointed as a Director was appointed as a Director on 07 Nov 2013 & has been associated with this company since 12 years 22 days . was recorded as a recent event.
Radha Dattatray Walaskar was appointed as a Director was appointed as a Director on 07 Nov 2013 & has been associated with this company since 12 years 22 days . was recorded as a recent event.
The activity Parmeshwar Annasaheb Lambud was appointed as a Managing Director was appointed as a Managing Director on 07 Nov 2013 & has been associated with this company since 12 years 22 days . was completed.
Progress on Vijaya Vinod Lambud was appointed as a Director was appointed as a Director on 07 Nov 2013 & has been associated with this company since 12 years 22 days . was documented.
The CIN of Sprash Pharmaceutical Private Limited is U24233MH2013PTC249883.
Sprash Pharmaceutical Private Limited is headquartered at Flat No. 302, 3Rd Floor, Tirupati Gaurav Society Survey No. 416/2, Belapur, Thane, Maharashtra, 400614.
Sprash Pharmaceutical Private Limited was incorporated on 07 November 2013.
The current directors of Sprash Pharmaceutical Private Limited are
The primary industry of Sprash Pharmaceutical Private Limited is Trade.
Sprash Pharmaceutical Private Limited is unlisted.
The authorized capital of Sprash Pharmaceutical Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Sprash Pharmaceutical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX